ALVAC-CEA vaccine
|
WikiDoc Resources for ALVAC-CEA vaccine |
|
Articles |
|---|
|
Most recent articles on ALVAC-CEA vaccine Most cited articles on ALVAC-CEA vaccine |
|
Media |
|
Powerpoint slides on ALVAC-CEA vaccine |
|
Evidence Based Medicine |
|
Cochrane Collaboration on ALVAC-CEA vaccine |
|
Clinical Trials |
|
Ongoing Trials on ALVAC-CEA vaccine at Clinical Trials.gov Trial results on ALVAC-CEA vaccine Clinical Trials on ALVAC-CEA vaccine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on ALVAC-CEA vaccine NICE Guidance on ALVAC-CEA vaccine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on ALVAC-CEA vaccine Discussion groups on ALVAC-CEA vaccine Patient Handouts on ALVAC-CEA vaccine Directions to Hospitals Treating ALVAC-CEA vaccine Risk calculators and risk factors for ALVAC-CEA vaccine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for ALVAC-CEA vaccine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ALVAC-CEA vaccine is a cancer vaccine containing a canary pox virus (ALVAC) combined with the human carcinoembryonic antigen (CEA) gene.
External links
- ALVAC-CEA vaccine entry in the public domain NCI Dictionary of Cancer Terms